Concepedia
Publication | Open Access
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
220
Citations
16
References
2018
Year
Clinical trials.gov identifier: NCT02258659.
Page 1